Computer-aided discovery, design, and investigation of COVID-19 therapeutics

Chun-Chun Chang1,2, Hao-Jen Hsu3, Tien-Yuan Wu4

  • 1Department of Laboratory Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Insights

Computational methods accelerate drug discovery for COVID-19. Structure-based drug design and repurposing of existing drugs, including herbal medicines, offer promising therapeutic strategies against SARS-CoV-2 variants.

Area of Science:

  • Biomedical Research
  • Computational Chemistry
  • Drug Discovery

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, necessitates urgent development of effective therapeutics.
  • Rapid mutation of SARS-CoV-2 leads to breakthrough infections in vaccinated individuals, highlighting the need for diverse treatment options.
  • Advancements in computational technology offer powerful tools for accelerating pharmaceutical research and drug development.

Purpose of the Study:

  • To review the application of computational methods in discovering and designing novel drugs for COVID-19 treatment.
  • To explore the repurposing of existing drugs as potential therapeutics against SARS-CoV-2.
  • To discuss computer-aided strategies for identifying effective compounds, peptides, and herbal medicines.

Main Methods:

  • Structure-based computational approaches, including molecular docking and molecular dynamics simulations.
  • Utilizing resolved three-dimensional structures of major SARS-CoV-2 proteins from the Protein Data Bank.
  • Screening of potential therapeutic compounds, functional peptides, and herbal medicine-derived molecules.

Main Results:

  • Computational methods significantly reduce costs and simplify pharmaceutical drug development processes.
  • Structure-based computations provide a foundation for rational drug design against SARS-CoV-2.
  • Computer-aided investigations have identified potential therapeutic candidates for COVID-19.

Conclusions:

  • Computational methods are crucial for efficient drug discovery and development in response to the COVID-19 pandemic.
  • Structure-based drug design and drug repurposing are vital strategies for combating SARS-CoV-2.
  • The integration of computational approaches with traditional medicine offers novel avenues for COVID-19 therapeutics.